BofA Securities Maintains Intellia Therapeutics(NTLA.US) With Buy Rating, Maintains Target Price $50

Moomoo News11:31 ET · Ratings

Strategic Focus and Financial Resilience: Terence Flynn's Positive Outlook on Intellia Therapeutics

TipRanksJan 11 10:36 ET

Barclays Maintains Intellia Therapeutics(NTLA.US) With Buy Rating, Maintains Target Price $55

Moomoo NewsJan 11 10:32 ET · Ratings

Analysts' Top Healthcare Picks: Inozyme Pharma (INZY), Intellia Therapeutics (NTLA)

TipRanksJan 11 10:30 ET · Ratings

A Quick Look at Today's Ratings for Intellia Therapeutics(NTLA.US), With a Forecast Between $29 to $60

Moomoo NewsJan 11 08:00 ET · Ratings

Intellia Therapeutics Price Target Lowered to $60 From $70 at Wells Fargo

Yahoo FinanceJan 11 07:36 ET